Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Storefront showing pharmacy services

Setting up a pharmacy provider company to win tenders for new servicesSubscription

With public health bodies and clinical commissioning groups now seeking single organisations to manage local services, Steve Hemsley examines the benefits for community pharmacists and pharmacies when creating pharmacy provider companies to tender for new services, as well as the risks and challenges posed by this new approach. 

Jenga blocks symbolising risks and opportunities for the UK drug regulator post-brexit

Drug regulation in the UK: risks and opportunities post-BrexitSubscription

While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.

Emergency contraception

GPhC consultation on religious beliefs generates record number of responses

Proposals that would prevent a pharmacist from referring a patient elsewhere on the grounds that their personal religious beliefs prevented them from providing the necessary care have triggered a record number of responses, the General Pharmaceutical Council says.

More news

Close up of a health worker examining a toddler's ear

How to diagnose and manage primary and secondary earache and ear infectionsSubscription

Earache is a common problem that can be the result of a variety of different pathologies. It is important for pharmacists and healthcare professionals to appropriately diagnose primary and secondary earache and ear infections.

More learning articles

Storefront showing pharmacy services

Setting up a pharmacy provider company to win tenders for new servicesSubscription

With public health bodies and clinical commissioning groups now seeking single organisations to manage local services, Steve Hemsley examines the benefits for community pharmacists and pharmacies when creating pharmacy provider companies to tender for new services, as well as the risks and challenges posed by this new approach. 

Dr Rania Hallaq, holistic assessment and rapid investigation (HARI) clinical pharmacist

What Rania Hallaq does as a holistic assessment and rapid investigation clinical pharmacist

The multidisciplinary holistic assessment and rapid investigation team assesses, investigates and treats referred patients with multiple complex medical and rehabilitation needs. Clinical pharmacist Rania Hallaq talks about the demands of running a clinic, problem-solving and managing complex patients.

More career articles

Illustration of a hand putting vote in ballot box

It’s RPS national board election time againSubscription

Alex MacKinnon, interim chief executive of the Royal Pharmaceutical Society, makes a plea for members to use their vote in the 2017 national board elections.

More Your RPS

Big data concept

Could big data be the future of pharmacy?Subscription

The information gleaned from vast amounts of data presents a promising way to maximise the value of medicines, from identifying poor adherence to improving quality of prescribing. Projects in both the UK and the United States are doing just that.

Collage of smart inhaler with patient, doctor and mobile devices

Smart inhalers: will they help to improve asthma care?Subscription

Smart inhalers use Bluetooth technology to detect inhaler use, remind patients when to take their medication and gather data to help guide care. They have the potential to improve patients’ adherence to asthma therapies and keep their condition under control, but it is clear they need to be designed with health systems and patients in mind so that they can offer maximum benefit.

GP out of hours service sign

New urgent drug supply scheme adds a layer of difficultySubscription

The new urgent medicines supply service takes the load off out-of-hours GP services, but adds bureaucracy for patients and pharmacists.

More features

Special report

RPS National Pharmacy Board Elections 2017

During May 2017, members and fellows of the Royal Pharmaceutical Society (RPS) will vote to elect candidates to the National Pharmacy Board. Read letters from the hopefuls on this special election page. Voting opens 4 May.

Read on

White Paper

Headaches in children: An unmet need

Pharmacist Christine Glover discusses the need for greater awareness and better management of paediatric headache in community pharmacy.

This article was commissioned, briefed and fully funded by RB.

Read on

Jenga blocks symbolising risks and opportunities for the UK drug regulator post-brexit

Drug regulation in the UK: risks and opportunities post-BrexitSubscription

While the implications of Brexit on drug regulation in the UK are largely unknown, the government needs to consider its options quickly to avoid delaying public access to important medicine.

Scientists pushing pills around model human body

Rare but not forgotten: why drug appraisal methods must be updated to consider treatments for rare diseasesSubscription

The UK government needs to adapt its drug and technology appraisal methods to prevent patients with rare diseases being left out in the cold.

More opinion

Diagram showing different pharmacy organisations in the UK and who they represent

Pharmacy organisations in the UK: a complicated webSubscription

Pharmacy is a diverse profession and this is reflected in the wide variety of organisations that can represent the interests of pharmacists, pharmacy owners, trainees and students. 

More infographics

Action of serotonin reuptake inhibitors

Depression in adults: recognition and managementSubscription

Pharmacists and healthcare professionals should be able to recognise the symptoms of depression in people who use their services and direct them towards accessing treatment. This article examines how a diagnosis of depression is made, the pharmacological and non-pharmacological treatments available, specific considerations for different patient groups, self-management approaches, and the role of the pharmacy team in managing and supporting patients who have symptoms of depression.

Micrograph of multiple myeloma tumour cells (green) and bone cells (red) growing on a scaffold made of silk protein (purple), designed to resemble bone material

Multiple myeloma: pharmacological management

Although multiple myeloma is currently regarded as being incurable in the majority of patients, the outlook for patients diagnosed with the condition has improved markedly over the last 40 years, with survival rates quadrupling. Significant advances in both treatment and supportive therapies have contributed to these improved outcomes and are discussed in this article.

More CPD modules

Sign at the building entrance of Shanghai General Hospital

My pharmacy summer placement in Shanghai, China

Shane Kailla describes his experience of pharmacy practice in Shanghai, China, during his 2016 summer placement.

Icons of diabetes,COPD and heart disease

Clinical Pharmacist calls for papers on long-term conditions

We are calling for article submissions that highlight best practice in relation to the management of long-term conditions.

Other blogs

Book cover of 'AHFS drug information 2017'

Comprehensive drug reference resource from the American Society of Health-System PharmacistsSubscription

This new edition of the popular drug reference includes oncology drugs approved under the US Food and Drug Administration’s accelerated approval programme.

More Books and arts

Research article

Molecular model of C-reactive protein

Evaluating a point-of-care C-reactive protein test to support antibiotic prescribing decisions in a general practiceSubscription

C-reactive protein (CRP) is a marker of infection and inflammation. It is high in bacterial infections but very low or close to zero in viral infections. The National Institute for Health and Care Excellence (NICE), England and Wales’s health technology assessment body, has issued guidance on pneumonia in adults; it recommends point-of-care (POC) CRP analysers when clinical assessment is inconclusive. If the CRP level is less than 20mg/L, no antibiotics ...

Oral anticoagulant therapy and INR blood test monitor

Assessing the impact of a targeted pharmacist-led anticoagulant review clinicSubscription

Local guidance, supported by the 2014 National Institute for Health and Care Excellence (NICE) guideline CG180 for atrial fibrillation (AF), recommends that patients receiving inadequate anticoagulation with a vitamin K antagonist (VKA), including time in therapeutic range (TTR) of <65%, should be reassessed. These patients were identified by the anticoagulation monitoring service (AMS) and highlighted to GPs for review. However, up to 59.3% of patients received ...

Close-up of a person taking a dry-blood spot test

Integrating community pharmacy testing for hepatitis C with specialist careSubscription

Many patients with hepatitis C virus (HCV) infection lie undiagnosed and a significant proportion of patients that have been identified are disengaged from specialist services. The Isle of Wight (IOW) typifies this issue, with an estimated 200 undiagnosed patients with HCV infection and a small number of known cases engaged with specialist services. Aim: To reduce the burden of undiagnosed HCV on the IOW and link new diagnoses directly ...

Woman breathes into a spirometre to check for COPD

Demonstrating the patient benefit and value for the NHS of community pharmacy: insight from the Community Pharmacy Future modelSubscription

By , ,

In the face of funding and efficiency cuts to community pharmacy, the role of the sector is coming under increasing pressure. The importance of outcomes evidence (particularly health economic evidence) is being brought sharply into focus. The profession must come together to produce the evidence needed to justify the services provided by community pharmacy and to support its future development. This article uses the Community Pharmacy Future (CPF) project, and the services developed ...

More perspective articles

Fluoroscopic examination of gastrointestinal (GI) tract showing inflammatory bowel disease (IBD)

Management of patients with inflammatory bowel disease: current and future treatmentsSubscription

By ,

Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal tract and affects patients’ quality of life. Treatment of IBD involves induction and maintenance of remission. Current available therapies include anti-inflammatory aminosalicylates and corticosteroids, immunosuppressive agents, antibiotics and biologic agents. Some patients are not fully responsive to conventional treatment or lose efficacy over time. Recently approved ...

More review articles

A reference you need

British National Formulary, 71st edition

Up-to-date, practical guidance on prescribing, dispensing, administering medicines and current best practice relating to the uses of medicines, as well as legal and professional guidelines.

Order your copy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.